Avoid the IPO. Hundreds of Pathology Labs are there in Delhi and this is just another small local lab. Only PAN India players like Thyrocare, Dr. LalPathLab those are listed in mainboard can only survive and snatching market share from those small local players. Many venture capital backed start-ups are entering in this space having deep pocket and offering big discount, making these small players difficult to sustain. Amazon will also enter in this space. So, huge competition coming and only big players like Thyrocare only survive and grow.